<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3346/jkms.2007.22.2.192</article-id><article-id pub-id-type="pmid">17449922</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A Useful Predictor of Early Atherosclerosis in Obese Children: Serum High-sensitivity C-reactive Protein</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roh</surname><given-names>Eui Jung</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Jae Woo</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Ko</surname><given-names>Kyoung Og</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cheon</surname><given-names>Eun Jung</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Pediatrics, College of Medicine, Konyang University, Daejeon, Korea.</aff><author-notes><corresp> Address for correspondence: Eun Jung Cheon, M.D. Department of Pediatrics, College of Medicine, Konyang University, 685 Gasoowon-dong, Seo-gu, Daejeon 302-241, Korea. Tel: +82.42-600-9230, Fax: +82.42-600-9090, <email>kcm1000@kyuh.co.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>30</day><month>4</month><year>2007</year></pub-date><volume>22</volume><issue>2</issue><fpage>192</fpage><lpage>197</lpage><history><date date-type="received"><day>25</day><month>4</month><year>2006</year></date><date date-type="accepted"><day>16</day><month>8</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Childhood obesity seems to contribute to the development of vascular inflammation and the progression of arterial wall changes. High-sensitivity C-reactive protein (hs-CRP) has recently emerged as a useful biomarker for vascular inflammation associated with atherosclerosis. The objectives of this study were to evaluate the association of the serum hs-CRP level with ultrasonic findings of early atherosclerosis, carotid intima-media wall thickness (IMT) and brachial flow-mediated dilation (FMD), in obese children. Thirty eight obese children and 45 sex/age-matched healthy control children were recruited. Serum CRP levels were measured by the high-sensitive latex turbidimetric immunoassay, and we measured carotid IMT and brachial FMD using high-resolution B-mode ultrasonography. Obese children had significantly higher hs-CRP levels (1.40&#x000b1;0.74 mg/L vs. 0.55&#x000b1;0.49 mg/L, <italic>p</italic>&#x0003c;0.01), as well as increased IMT (0.52&#x000b1;0.09 mm vs. 0.41&#x000b1;0.07 mm, <italic>p</italic>&#x0003c;0.01) and impaired FMD (7.35&#x000b1;7.78% vs. 20.34&#x000b1;16.81%, <italic>p</italic>&#x0003c;0.01) compared to healthy controls. Serum hs-CRP correlated positively with IMT (r=0.413, <italic>p</italic>&#x0003c;0.05) and inversely with FMD (r=-0.350, <italic>p</italic>&#x0003c;0.05) in the obesity group. Measurement of the serum hs-CRP level is a simple, cheap, and highly reproducible assay and correlates with IMT and FMD in obese children. Thus, it would be a useful marker for evaluating and estimating the degree of atherosclerosis in children.</p></abstract><kwd-group><kwd>C-reactive Protein</kwd><kwd>Intima-media Thickness</kwd><kwd>Flow-mediated Dilation</kwd><kwd>Obesity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Current evidence indicates that chronic subclinical inflammation may play an important role in the genesis and progression of atherosclerosis, and many recent reports have explored the association between C-reactive protein (CRP) levels and atherosclerosis. CRP is present in the acute reaction phase of inflammation, and elevated levels of serum CRP are related to a poorer outcome in patients with cardiovascular diseases (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p><p>Several studies have suggested that CRP is a predictor of subsequent cardiovascular events in healthy adults (<xref ref-type="bibr" rid="B3">3</xref>). Recently, high-sensitivity C-reactive protein (hs-CRP) has emerged as a useful biomarker for vascular inflammation associated with atherosclerosis. While a significant amount of data has been amassed about vascular disease in adults, limited data exists concerning the low grade inflammation in obese children. Because atherosclerosis frequently begins in childhood, we assessed the association of two markers of early atherosclerosis, serum hs-CRP level and atherosclerotic risk factors with carotid intima-media wall thickness (IMT) and brachial flow-mediated dilation (FMD) in obese children.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Subjects</title><p>The study subjects were 83 children. Thirty-eight children were obese (14-16 yr of age, male), and 45 were sex/age-matched healthy control children. All were nonsmokers without any regular medication and had no family history of premature vascular disease. None of the children had symptoms of infection during the 2 weeks before the study.</p></sec><sec><title>Anthropometric measurement and clinical examination</title><p>Body height and weight were measured in light clothes using a portable standiometer. Body mass index (BMI) was calculated as weight divided by the square of the height (kg/m<sup>2</sup>). In children, the 95th percentile for BMI in the 2000 CDC growth chart is 21-23 (<xref ref-type="bibr" rid="B4">4</xref>), so we used BMI &#x0003e;23 as our prospectively defined criterion for obesity, and BMI &#x0003c;21 was defined as the non-obese control level.</p></sec><sec><title>Serum lipids and apolipoprotein</title><p>Venous blood samples were taken in the morning after overnight fasting (10-12 hr). Serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglyceride (TG) concentrations were measured by standard enzymatic methods with the use of Boehringer Mannheim GmbH and a fully automatic analyzer. Serum apolipoprotein A-1 (Apo A-1), apolipoprotein B (Apo B), and apolipoprotein E (Apo E) were measured by immunonephelometry (Behring Nephelometer II, Dade Behring, Inc., Newark, DE, U.S.A.).</p></sec><sec><title>High-sensitivity C-reactive protein</title><p>A BN II Nephelometer Analyzer (Dade Behring, Inc.) was used to measure serum hs-CRP values using a high sensitivity latex-enhanced immunonephelometric assay method. The detection limit of this assay was 0.17 mg/dL. Because the 90th percentile of normal CRP distribution is 0.3 mg/dL, we included only patients with CRP values below 0.3 mg/dL to avoid the influence of acute infection.</p></sec><sec><title>Ultrasound studies</title><p>All ultrasound studies were performed in the morning on fasting subjects with the use of Hewlett-Packard Sonos 5500 and a 3-11 MHz linear array transducer (Philips, Andover, Massachusetts, U.S.A.). All ultrasound scans were performed by an experienced vascular operator who was unaware of the children's clinical details. Blood pressure was measured from the brachial artery of the nondominant arm 3 times during the ultrasound study with the use of a standard sphygmomanometer, and the mean value of these 3 measurements was used for the analyses. The brachial artery evaluations and carotid artery evaluations were performed by using standard techniques for the study of children.</p></sec><sec><title>Brachial artery evaluation</title><p>Brachial artery diameter was measured during reactive hyperemia from B-mode ultrasound images at rest. The subjects lay quietly for 10 min before the first scan. The brachial artery was scanned in a longitudinal section 5 to 15 cm above the elbow. Depth and gain settings were set to optimize images of the lumen-arterial wall interface, and the operating parameters were kept constant during the study. A resting scan was performed, and the arterial flow velocity was measured using a Doppler signal. Increased flow was then induced by inflation of a pneumatic tourniquet placed around the forearm (distal to the scanned part of the artery) to a pressure of 250 mmHg for 5 min, followed by release. Subsequent scans were taken continuously for 60 sec after cuff deflation. We also included a repeated flow velocity recording for the first 15 sec after the cuff was released. Vessel diameter was measured by an experienced reader who were blind to the study subjects' laboratory data. The arterial diameter was measured at a fixed distance from an anatomic marker with the use of ultrasonic calipers. Measurements were taken from the anterior to the posterior M line at end diastole, incident with the R wave on a continuously recorded ECG. The maximal proportional dilatation from baseline (FMD) was assessed.</p></sec><sec><title>Carotid artery analysis</title><p>Carotid artery IMT measurements were done according to a predetermined, standardized scanning protocol for the right carotid artery. Briefly, the proximal part of the carotid bulb was identified and the segments of the common carotid arteries 1 to 2 cm proximal to the bulb were scanned. The image was focused on the posterior wall, and the resolution box function was used to magnify the arterial far wall. All scans were digitally stored for subsequent offline analysis. One end-diastolic frame (captured adjacent to the R wave on a continuously recorded ECG) for each interrogation angle was selected and analysed for mean IMT. Five measurements for far wall IMT were taken manually for each image using ultrasonic calipers, and the average values of these readings were used for the analyses.</p></sec><sec><title>Statistical analyses</title><p>SPSS version 11.0 was used for all statistical calculations. Results were expressed as mean&#x000b1;standard deviation. Comparisons between two groups were performed by the independent student-t test. Univariate and multivariate regression analyses were used to dclineate the relationships between arterial changes and CRP. Due to the skewed distribution of hs-CRP levels, CRP values were logarithmically transformed prior to regression analyses. For all analyses, probability (<italic>p</italic>) values below 0.05 were considered statistically significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Clinical characteristics</title><p>Height and weight were significantly higher in the obesity group than in the control group. BMI was 29.40&#x000b1;3.18 kg/m<sup>2</sup> in the obesity group and was 18.43&#x000b1;1.00 kg/m<sup>2</sup> in the control group (<xref ref-type="table" rid="T1">Table 1</xref>). Obese children had significantly higher systolic blood pressure (SBP) (133.05&#x000b1;8.84 mmHg vs. 115.16&#x000b1;8.62 mmHg), diastolic blood pressure (DBP) (84.95&#x000b1;9.02 mmHg vs. 75.16&#x000b1;6.92 mmHg), hs-CRP levels (0.10&#x000b1;0.07 mg/dL vs. 0.06&#x000b1;0.04 mg/dL, <italic>p</italic>&#x0003c;0.01) and significantly higher LDL-C, TG, Apo B and lower HDL-C than the control group (<xref ref-type="table" rid="T2">Table 2</xref>). TC and Apo E were higher and Apo A-1 was lower in the obesity group than in the control group, but these differences were not statistically significant.</p></sec><sec><title>Ultrasonic findings</title><p>Obese children were also found to have increased IMT (0.52&#x000b1;0.09 mm vs. 0.40&#x000b1;0.07 mm, <italic>p</italic>&#x0003c;0.001) and impaired FMD (7.35&#x000b1;7.78% vs. 20.34&#x000b1;16.81%, <italic>p</italic>&#x0003c;0.001) compared to healthy controls (<xref ref-type="table" rid="T3">Table 3</xref>).</p></sec><sec><title>Relationships between IMT, FMD and atherosclerotic risk factors</title><p>IMT correlated with BMI (r=0.612, <italic>p</italic>&#x0003c;0.001), SBP (r=0.510, <italic>p</italic>&#x0003c;0.001), DBP (r=0.307, <italic>p</italic>&#x0003c;0.05), and HDL-C (r=-0.221, <italic>p</italic>&#x0003c;0.05). FMD correlated with BMI (r=-0.414, <italic>p</italic>&#x0003c;0.001), SBP (r=-0.437, <italic>p</italic>&#x0003c;0.001), TG (r=-0.445, <italic>p</italic>&#x0003c;0.05), and Apo E (r=-0.402, <italic>p</italic>&#x0003c;0.05) (<xref ref-type="table" rid="T4">Table 4</xref>).</p></sec><sec><title>Relationships between hs-CRP and atherosclerotic risk factors</title><p>Log [CRP] showed a positive correlation with BMI (r=0.470, <italic>p</italic>&#x0003c;0.001), SBP (r=0.209, <italic>p</italic>&#x0003c;0.05), DBP (r=0.230, <italic>p</italic>&#x0003c;0.05), Apo E (r=0.308, <italic>p</italic>&#x0003c;0.01), and TG (r=0.288, <italic>p</italic>&#x0003c;0.05) by simple regression (<xref ref-type="table" rid="T5">Table 5</xref>).</p></sec><sec><title>Relationships between hs-CRP and ultrasonic findings</title><p>Serum hs-CRP correlated positively with IMT (r=0.413, <italic>p</italic>&#x0003c;0.05) and inversely with FMD (r=-0.350, <italic>p</italic>&#x0003c;0.05) in the obesity group (<xref ref-type="fig" rid="F1">Fig. 1</xref>, <xref ref-type="fig" rid="F2">2</xref>).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The present study showed that elevated serum CRP levels were significantly associated with endothelial dysfunction and increased carotid artery IMT in obese children. While there have been many previous studies relating CRP and cardiovascular risk factors (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>), the association of CRP with subclinical atherosclerotic findings has been examined primarily in adults, with few studies in obese children (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>).</p><p>Historically, CRP has been measured in clinical laboratories by immunoturbidimetric and immunonephelometric assays designed to detect active inflammation and infection. The dynamic range of these assays is from 3 mg/L (90th percentile of the general population) to well over 200 mg/L. Although such assays are automated and reproducible, they have a relatively low detection limit of 3 to 8 mg/L and thus do not have appropriate sensitivity in the range required for the determination of cardiovascular risk (<xref ref-type="bibr" rid="B9">9</xref>). To achieve the desired limit of quantification, hs-CRP assays have been developed that can reliably measure hs-CRP concentrations as low as 0.15 mg/L (&#x0003c;2.5th percentile of the general population). When measured with a high-sensitivity assay, CRP levels appear to have a predictive value for cardiovascular morbidity and mortality. Moreover, baseline levels of CRP predict the risk of future myocardial infarction, stroke, and peripheral atherosclerosis, even after adjustment for other known cardiovascular risk factors (<xref ref-type="bibr" rid="B10">10</xref>). We employed this method in the present study, and we found that obese children had significantly higher hs-CRP levels than control subjects. Further studies will be required to determine cut-off values for hs-CRP in obese children.</p><p>High-resolution ultrasound is a reliable, noninvasive method for detecting early structural and functional atherosclerotic changes in the arterial wall. Increased carotid IMT is a structural marker of early atherosclerosis that correlates with vascular risk factors and is related to the severity and extent of coronary artery disease. FMD of the brachial artery is a marker of endothelial function that can be assessed by measuring arterial diameter responses to increased flow (<xref ref-type="bibr" rid="B11">11</xref>). Brachial artery FMD occurs mainly as the result of endothelial release of nitric oxide and correlates with coronary endothelial function (<xref ref-type="bibr" rid="B12">12</xref>). Both increased IMT and impaired FMD have been detected in young children who have risk factors for atherosclerosis such as familial hypercholesterolemia (<xref ref-type="bibr" rid="B13">13</xref>) and diabetes (<xref ref-type="bibr" rid="B14">14</xref>). In the present study, obese children were also found to have increased IMT and impaired FMD compared to the healthy controls. In addition, IMT was positively correlated with BMI, SBP, and DBP, and negatively correlated with HDL-C concentrations. Zhu et al. reported a similar result in 43 obese children (<xref ref-type="bibr" rid="B15">15</xref>), and Kim et al. showed that IMT correlated with DBP and homocysteine concentrations (<xref ref-type="bibr" rid="B16">16</xref>).</p><p>Woo et al. have confirmed that the degree of endothelial dysfunction correlated with BMI as assessed by multivariate analysis (<xref ref-type="bibr" rid="B17">17</xref>). In the current study, FMD was shown to correlate with BMI, SBP, and TG and Apo E concentrations.</p><p>Traditional risk factors for cardiovascular disease include aging, hypertension, dyslipidemia, smoking, and diabetes. The contribution of lipid accumulation to atherosclerotic disease is well known, but laboratory and experimental evidence indicates that chronic inflammatory processes also play an important role in the development of atherosclerosis (<xref ref-type="bibr" rid="B18">18</xref>). In order to effectively prevent the incidence of cardiovascular events, it is important to weigh the influence of each risk factor on the cardiovascular system. In addition, it should be borne in mind that various cardiovascular factors are not independent of one another but often have direct or indirect interactions (<xref ref-type="bibr" rid="B19">19</xref>). In this respect, we investigated the relationship of inflammatory markers with other risk factors. Elevated serum CRP levels were positively associated with elevated BMI, confirming previous observations in both children (<xref ref-type="bibr" rid="B19">19</xref>) and adults (<xref ref-type="bibr" rid="B20">20</xref>). The mechanisms underlying this association with BMI or obesity might be as follows; the adipose tissue is a source of cytokines such as tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6), and these cytokines stimulate the production of acute-phase proteins such as C-reactive protein in the liver (<xref ref-type="bibr" rid="B21">21</xref>). Not unexpectedly, then, we found that serum CRP levels were positively associated with BMI. Because we have not checked proinflammatory cytokines such as TNF-a and IL-6, we can not verify the elevation of these cytokines as a consequence of obesity.</p><p>In addition to BMI, CRP was also found to be closely correlated with SBP, DBP, and ApoE and TG concentrations. Previous studies reported that CRP levels are significantly positively correlated with TG, total ratio of serum cholesterol to serum HDL cholesterol (<xref ref-type="bibr" rid="B22">22</xref>), fibrinogen levels, heart rate, SBP (<xref ref-type="bibr" rid="B19">19</xref>), smoking, and white blood cell count (<xref ref-type="bibr" rid="B5">5</xref>) and negatively correlated with HDL-C levels (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Several studies have examined the relationship between CRP and carotid IMT in adults. Hak et al. found a highly significant relationship between markers of obesity and CRP in healthy, middle-aged women, but failed to find a significant relationship between CRP and subclinical atherosclerosis of the carotid system (<xref ref-type="bibr" rid="B20">20</xref>). Sitzer et al. performed a large scale study that showed the serum CRP level is linearly positively correlated with IMT in apparently healthy adults (<xref ref-type="bibr" rid="B3">3</xref>). Hayaishi et al. reported that the hs-CRP level is positively associated with carotid IMT in young patients with type 1 diabetes (<xref ref-type="bibr" rid="B23">23</xref>). Several studies have also shown an association between elevated CRP concentrations and endothelial dysfunction in adult patients with coronary artery disease (<xref ref-type="bibr" rid="B24">24</xref>) and with type 2 diabetes (<xref ref-type="bibr" rid="B25">25</xref>). In contrast to the significant amount of data that has accumulated from adult individual, limited data exists concerning CRP and subclinical atherosclerosis in children. Jarvisalo et al. reported that, in healthy children, elevated serum CRP levels were significantly associated with decreased endothelial vasodilatory function and increased IMT (<xref ref-type="bibr" rid="B26">26</xref>). Our results are consistent with the Mangge's report (<xref ref-type="bibr" rid="B27">27</xref>) that serum hs-CRP correlated positively with IMT and inversely with FMD in the obesity group. In other words, if hs-CRP is increased in asymptomatic obese children, we can assume the existence of and advanced subclinical atherosclerosis, increased IMT, and decreased endothelial vasodilatory function without performing an ultrasound.</p><p>In summary, we found a highly significant correlation between the serum CRP concentration and the early stage of atherosclerosis in obese children. Although ultrasonography allows visualization of early subclinical stages of atherosclerosis in obese children, the measurement of the serum hs-CRP level is simpler and cheaper than ultrasonography, is highly reproducible, and well correlates with IMT and FMD in obese children. Thus, hs-CRP would be a useful screening marker for evaluating and estimating the degree of atherosclerosis in children.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This study was supported by a grant from the <funding-source>Korea Research Foundation</funding-source> (<award-id>KRF-2005-E00208</award-id>).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haverkate</surname><given-names>F</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Pyke</surname><given-names>SD</given-names></name><name><surname>Gallimore</surname><given-names>JR</given-names></name><name><surname>Pepys</surname><given-names>MB</given-names></name></person-group><article-title>Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group</article-title><source>Lancet</source><year>1997</year><volume>349</volume><fpage>462</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">9040576</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liuzzo</surname><given-names>G</given-names></name><name><surname>Biasucci</surname><given-names>LM</given-names></name><name><surname>Gallimore</surname><given-names>JR</given-names></name><name><surname>Grillo</surname><given-names>RL</given-names></name><name><surname>Rebuzzi</surname><given-names>AG</given-names></name><name><surname>Pepys</surname><given-names>MB</given-names></name><name><surname>Maseri</surname><given-names>A</given-names></name></person-group><article-title>The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina</article-title><source>N Engl J Med</source><year>1994</year><volume>331</volume><fpage>417</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">7880233</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Shaten</surname><given-names>J</given-names></name><name><surname>Meilahn</surname><given-names>FN</given-names></name></person-group><article-title>Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial</article-title><source>Am J Epidemiol</source><year>1996</year><volume>144</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">8797513</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogden</surname><given-names>DL</given-names></name><name><surname>Kuczmarski</surname><given-names>RJ</given-names></name><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Mel</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Wel</surname><given-names>R</given-names></name><name><surname>Grummer-Strawn</surname><given-names>LM</given-names></name><name><surname>Gurtin</surname><given-names>LR</given-names></name><name><surname>Roche</surname><given-names>AF</given-names></name><name><surname>Johnson</surname><given-names>CL</given-names></name></person-group><article-title>Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version</article-title><source>Pediatrics</source><year>2002</year><volume>109</volume><fpage>45</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11773541</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Ishimitsu</surname><given-names>T</given-names></name><name><surname>Minami</surname><given-names>J</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Ohrui</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>H</given-names></name></person-group><article-title>Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors</article-title><source>Atherosclerosis</source><year>2003</year><volume>167</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12618270</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>MG</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name></person-group><article-title>Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors</article-title><source>J Korean Med Sci</source><year>2005</year><volume>20</volume><fpage>379</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">15953856</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitzer</surname><given-names>M</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name><name><surname>Mendall</surname><given-names>MA</given-names></name><name><surname>Liehr</surname><given-names>R</given-names></name><name><surname>Knorr</surname><given-names>U</given-names></name><name><surname>Steinmetz</surname><given-names>H</given-names></name></person-group><article-title>C-reactive protein and carotid intimal medial thickness in a community population</article-title><source>J Cardiovasc Risk</source><year>2002</year><volume>9</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">12006917</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Kitagawa</surname><given-names>K</given-names></name><name><surname>Hougaku</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Nagai</surname><given-names>Y</given-names></name><name><surname>Iyama</surname><given-names>S</given-names></name><name><surname>Yamanishi</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name></person-group><article-title>C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11435339</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease</article-title><source>Clinical Chemistry</source><year>2001</year><volume>47</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">11238289</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohde</surname><given-names>LE</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men</article-title><source>Am J Cardiol</source><year>1999</year><volume>84</volume><fpage>1018</fpage><lpage>1022</lpage><pub-id pub-id-type="pmid">10569656</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvisalo</surname><given-names>MJ</given-names></name><name><surname>Raitakari</surname><given-names>M</given-names></name><name><surname>Toikka</surname><given-names>JO</given-names></name><name><surname>Putto-Laurila</surname><given-names>A</given-names></name><name><surname>Rontu</surname><given-names>R</given-names></name><name><surname>Laine</surname><given-names>S</given-names></name><name><surname>Lehtimaki</surname><given-names>T</given-names></name><name><surname>Ronnemaa</surname><given-names>T</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>1750</fpage><lpage>1755</lpage><pub-id pub-id-type="pmid">15023875</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joannides</surname><given-names>R</given-names></name><name><surname>Haefeli</surname><given-names>WE</given-names></name><name><surname>Linder</surname><given-names>L</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name><name><surname>Bakkali</surname><given-names>EH</given-names></name><name><surname>Thuillez</surname><given-names>C</given-names></name><name><surname>Luscher</surname><given-names>TF</given-names></name></person-group><article-title>Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>1314</fpage><lpage>1319</lpage><pub-id pub-id-type="pmid">7867167</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Gooch</surname><given-names>VM</given-names></name><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Miller</surname><given-names>OI</given-names></name><name><surname>Sullivan</surname><given-names>ID</given-names></name><name><surname>Lloyd</surname><given-names>JK</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis</article-title><source>Lancet</source><year>1992</year><volume>340</volume><fpage>1111</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">1359209</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>TP</given-names></name><name><surname>Groehn</surname><given-names>H</given-names></name><name><surname>Kazmers</surname><given-names>A</given-names></name></person-group><article-title>Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>41</volume><fpage>661</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">12598080</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Neubauer</surname><given-names>H</given-names></name></person-group><article-title>Arterial intima-media thickening and endothelial dysfunction in obese chinese children</article-title><source>Eur J Pediatr</source><year>2005</year><volume>164</volume><fpage>337</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">15750804</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Shim</surname><given-names>YH</given-names></name><name><surname>Yoo</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Hong</surname><given-names>YM</given-names></name></person-group><article-title>Measurement of the common carotid artery by ultrasound as a predictor of atherosclerosis in obese adolescents</article-title><source>Korean J Pediatr</source><year>2005</year><volume>48</volume><fpage>745</fpage><lpage>752</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>KS</given-names></name><name><surname>Chook</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>CW</given-names></name><name><surname>Sung</surname><given-names>RY</given-names></name><name><surname>Qiao</surname><given-names>M</given-names></name><name><surname>Leung</surname><given-names>SS</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><name><surname>Metreweli</surname><given-names>C</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name></person-group><article-title>Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening</article-title><source>Int J Obes Relat Metab Disord</source><year>2004</year><volume>28</volume><fpage>852</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">15170465</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Atherosclerosis-an inflammatory disease</article-title><source>New Engl J Med</source><year>1999</year><volume>340</volume><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">9887164</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>DG</given-names></name><name><surname>Mendall</surname><given-names>MA</given-names></name><name><surname>Whincup</surname><given-names>PH</given-names></name><name><surname>Carey</surname><given-names>IM</given-names></name><name><surname>Ballam</surname><given-names>L</given-names></name><name><surname>Morris</surname><given-names>JE</given-names></name><name><surname>Miller</surname><given-names>GJ</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name></person-group><article-title>C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors</article-title><source>Atherosclerosis</source><year>2000</year><volume>149</volume><fpage>139</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">10704625</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hak</surname><given-names>AE</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Polderman</surname><given-names>KH</given-names></name><name><surname>Schalkwijk</surname><given-names>CG</given-names></name><name><surname>Westendorp</surname><given-names>IC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name></person-group><article-title>Association of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle aged women</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1999</year><volume>19</volume><fpage>1986</fpage><lpage>1991</lpage><pub-id pub-id-type="pmid">10446082</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassuk</surname><given-names>SS</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>High-sensitivity C-reactive protein: clinical importance</article-title><source>Curr Probl Cardiol</source><year>2004</year><volume>29</volume><fpage>439</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">15258556</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>DM</given-names></name><name><surname>Chu</surname><given-names>NF</given-names></name><name><surname>Shen</surname><given-names>MH</given-names></name><name><surname>Chang</surname><given-names>JB</given-names></name></person-group><article-title>Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children</article-title><source>J Clin Epidemiol</source><year>2003</year><volume>56</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12589876</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayaishi-Okano</surname><given-names>R</given-names></name><name><surname>Yamasaki</surname><given-names>Y</given-names></name><name><surname>Katakami</surname><given-names>N</given-names></name><name><surname>Ohtoshi</surname><given-names>K</given-names></name><name><surname>Gorogawa</surname><given-names>S</given-names></name><name><surname>Kuroda</surname><given-names>A</given-names></name><name><surname>Matsuhisa</surname><given-names>M</given-names></name><name><surname>Kosugi</surname><given-names>K</given-names></name><name><surname>Nishikawa</surname><given-names>N</given-names></name><name><surname>Kajimoto</surname><given-names>Y</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name></person-group><article-title>Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes</article-title><source>Diabetes Care</source><year>2002</year><volume>25</volume><fpage>1432</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">12145246</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fichtlscherer</surname><given-names>S</given-names></name><name><surname>Rosenberger</surname><given-names>G</given-names></name><name><surname>Walter</surname><given-names>DH</given-names></name><name><surname>Breuer</surname><given-names>S</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name><name><surname>Zeiher</surname><given-names>AM</given-names></name></person-group><article-title>Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>1000</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">10961964</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>KC</given-names></name><name><surname>Chow</surname><given-names>WS</given-names></name><name><surname>Tam</surname><given-names>SC</given-names></name><name><surname>Ai</surname><given-names>VH</given-names></name><name><surname>Lam</surname><given-names>CH</given-names></name><name><surname>Lam</surname><given-names>KS</given-names></name></person-group><article-title>Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus</article-title><source>J Clin Endocrinol Metab</source><year>2002</year><volume>87</volume><fpage>563</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">11836286</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvisalo</surname><given-names>MJ</given-names></name><name><surname>Harmoinen</surname><given-names>A</given-names></name><name><surname>Hakanen</surname><given-names>M</given-names></name><name><surname>Paakkunainen</surname><given-names>U</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>Hartiala</surname><given-names>J</given-names></name><name><surname>Lehtimaki</surname><given-names>T</given-names></name><name><surname>Simell</surname><given-names>O</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name></person-group><article-title>Elevated serum C-reactive protein levels and early arterial changes in healthy children</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><fpage>1323</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">12171795</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangge</surname><given-names>H</given-names></name><name><surname>Schauenstein</surname><given-names>K</given-names></name><name><surname>Stroedter</surname><given-names>L</given-names></name><name><surname>Griesl</surname><given-names>A</given-names></name><name><surname>Maerz</surname><given-names>W</given-names></name><name><surname>Borkenstein</surname><given-names>M</given-names></name></person-group><article-title>Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2004</year><volume>112</volume><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">15239023</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Linear correlation of high-sensitivity C-reative protein (hs-CRP) and flow-mediated dilation (FMD) in the obesity group (r=-0.327, <italic>p</italic>&#x0003c;0.05, hs-CRP=6.472-1.89*FMD).</p></caption><graphic xlink:href="jkms-22-192-g001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p>Linear correlation of high-sensitivity C-reative protein (hs-CRP) and intima-media thickness (IMT) in the obesity group (r=0.437, <italic>p</italic>&#x0003c;0.05, hs-CRP=0.377+0.042*IMT).</p></caption><graphic xlink:href="jkms-22-192-g002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Comparison of characteristics between obesity and control groups</p></caption><graphic xlink:href="jkms-22-192-i001"/><table-wrap-foot><fn><p>Values are mean&#x000b1;standard deviation.</p><p>BMI, body mass index; BP, blood pressure; <italic>p</italic>, <italic>p</italic>-value.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of metabolic parameters between obesity and control groups</p></caption><graphic xlink:href="jkms-22-192-i002"/><table-wrap-foot><fn><p>Values are mean&#x000b1;standard deviation.</p><p>TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; Apo A-1, apolipoprotein A-1; Apo B, apolipoprotein B; Apo E, apolipoprotein E, hs-CRP; high-sensitivity C-reactive protein; <italic>p</italic>, <italic>p</italic>-value.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of ultrasonic findings between obesity and control groups</p></caption><graphic xlink:href="jkms-22-192-i003"/><table-wrap-foot><fn><p>Values are mean&#x000b1;standard deviation.</p><p>IMT, intima-media thickness; FMD, flow-mediated dilation; <italic>p</italic>, <italic>p</italic>-value.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Correlation of IMT and FMD with BMI, BP, lipid profile, and apolipoprotein concentrations</p></caption><graphic xlink:href="jkms-22-192-i004"/><table-wrap-foot><fn><p>IMT, intima-media thickness; FMD, flow-mediated dilation; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; Apo A-1, apolipoprotein A-1; Apo B, apolipoprotein B; Apo E, apolipoprotein E; r, correlation coefficient; <italic>p</italic>, <italic>p</italic>-value.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Correlation of log hs-CRP with BMI, BP, lipid profile, and apolipoprotein concentrations</p></caption><graphic xlink:href="jkms-22-192-i005"/><table-wrap-foot><fn><p>BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; Apo A-1, apolipoprotein A-1; Apo B, apolipoprotein B; Apo E, apolipoprotein E; r, correlation coefficient; <italic>p</italic>, <italic>p</italic>-value.</p></fn></table-wrap-foot></table-wrap></floats-group></article>